Jill Feldman/henryford.com
Apr 23, 2025, 06:24
Jill Feldman: Pneumonitis in lung cancer treatment
Jill Feldman, Co-Founder of EGFR Resisters and Lung Cancer Patient and Advocate, shared a post X:
“We must talk about pneumonitis in lung cancer treatment!
Resistance is horrible, but you understand the reasoning behind stopping treatment. When a treatment is working and has to be stopped due to pneumonitis, it sidelines patients and eliminates many future options – It is cruel and DEVASTATING!
This needs more attention, more research, and urgency to:
Understand who’s at risk?
Improve how it is managed.
Identify treatment options.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 23, 2025, 06:24
Apr 23, 2025, 01:36
Apr 22, 2025, 19:24
Apr 22, 2025, 18:28
Apr 22, 2025, 17:31
Apr 22, 2025, 16:58